900000000000509007: United States of America English language reference set (foundation metadata concept)

SNOMED CT Concept\SNOMED CT Model Component\Foundation metadata concept (foundation metadata concept)\Reference set\Language type reference set (foundation metadata concept)\English [International Organization for Standardization 639-1 code en] language reference set (foundation metadata concept)\US English

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 01-Jul 2024. Module: IPS terminology module (core metadata concept)

Descriptions:

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
US English	Is a	English [International Organization for Standardization 639-1 code en] language reference set (foundation metadata concept)	true	Inferred relationship	Some

Members	acceptabilityId
Esophagism	Acceptable (foundation metadata concept)
Esophagitis	Preferred (foundation metadata concept)
Esophagitis (disorder)	Preferred (foundation metadata concept)
Esophagogastrectomy	Preferred (foundation metadata concept)
Esophagogastrectomy (procedure)	Preferred (foundation metadata concept)
Esophagogastric fundoplasty	Preferred (foundation metadata concept)
Esophagogastric fundoplasty (procedure)	Preferred (foundation metadata concept)
Esophagogastric junction	Acceptable (foundation metadata concept)
Esophagogastroduodenoscopy	Preferred (foundation metadata concept)
Esophagogastroduodenoscopy (procedure)	Preferred (foundation metadata concept)
Esophagogastroduodenoscopy and biopsy	Acceptable (foundation metadata concept)
Esophagospasm	Acceptable (foundation metadata concept)
Esophagus	Acceptable (foundation metadata concept)
Esophagus, stomach, and duodenum.	Preferred (foundation metadata concept)
Esophagus, stomach, small intestine and large intestine together as a single entity.	Preferred (foundation metadata concept)
Esotropia	Preferred (foundation metadata concept)
Esotropia (disorder)	Preferred (foundation metadata concept)
Esotropia with accommodative compensation	Preferred (foundation metadata concept)
Esotropia with accommodative compensation (disorder)	Preferred (foundation metadata concept)
Essence	Acceptable (foundation metadata concept)
Essential blepharospasm	Acceptable (foundation metadata concept)
Essential familial hypercholesterolemia	Acceptable (foundation metadata concept)
Essential hemorrhagic thrombocythemia	Acceptable (foundation metadata concept)
Essential hypertension	Preferred (foundation metadata concept)
Essential hypertension (disorder)	Preferred (foundation metadata concept)
Essential hypertension complicating AND/OR reason for care during pregnancy	Preferred (foundation metadata concept)
Essential hypertension complicating AND/OR reason for care during pregnancy (disorder)	Preferred (foundation metadata concept)
Essential oil	Acceptable (foundation metadata concept)
Essential paroxysmal tachycardia	Acceptable (foundation metadata concept)
Essential thrombocythemia	Preferred (foundation metadata concept)
Essential thrombocythemia	Preferred (foundation metadata concept)
Essential thrombocythemia (clinical disorder)	Acceptable (foundation metadata concept)
Essential thrombocythemia (disorder)	Preferred (foundation metadata concept)
Essential thrombocythemia (morphologic abnormality)	Preferred (foundation metadata concept)
Essential thrombocytosis	Acceptable (foundation metadata concept)
Essential tremor	Preferred (foundation metadata concept)
Essential tremor (disorder)	Preferred (foundation metadata concept)
Establishes IV access	Acceptable (foundation metadata concept)
Ester	Preferred (foundation metadata concept)
Ester (substance)	Preferred (foundation metadata concept)
Esthesia	Acceptable (foundation metadata concept)
Esthesioneuroblastoma	Acceptable (foundation metadata concept)
Esthesioneuroblastoma	Acceptable (foundation metadata concept)
Estradiol	Preferred (foundation metadata concept)
Estradiol (substance)	Preferred (foundation metadata concept)
Estradiol and medroxyprogesterone only product	Preferred (foundation metadata concept)
Estradiol cypionate	Preferred (foundation metadata concept)
Estradiol cypionate (substance)	Preferred (foundation metadata concept)
Estradiol cypionate 10 mg/mL and medroxyprogesterone acetate 50 mg/mL prolonged-release suspension for injection	Preferred (foundation metadata concept)
Estrogen measurement	Preferred (foundation metadata concept)
Estrogen measurement (procedure)	Preferred (foundation metadata concept)
EtOH - Ethanol	Acceptable (foundation metadata concept)
Etanercept	Preferred (foundation metadata concept)
Etanercept (substance)	Preferred (foundation metadata concept)
Etanercept 25 mg powder for solution for injection vial	Preferred (foundation metadata concept)
Etanercept 50 mg powder for solution for injection vial	Preferred (foundation metadata concept)
Etanercept only product	Preferred (foundation metadata concept)
Ethambutol	Preferred (foundation metadata concept)
Ethambutol (substance)	Preferred (foundation metadata concept)
Ethambutol 100 mg dispersible oral tablet	Preferred (foundation metadata concept)
Ethambutol 100 mg tablet for oral suspension	Acceptable (foundation metadata concept)
Ethambutol and isoniazid and pyrazinamide and rifampicin only product	Acceptable (foundation metadata concept)
Ethambutol and isoniazid and pyrazinamide and rifampin only product	Preferred (foundation metadata concept)
Ethambutol and isoniazid and rifampicin only product	Acceptable (foundation metadata concept)
Ethambutol and isoniazid and rifampin only product	Preferred (foundation metadata concept)
Ethambutol hydrochloride	Preferred (foundation metadata concept)
Ethambutol hydrochloride (substance)	Preferred (foundation metadata concept)
Ethambutol hydrochloride 100 mg oral tablet	Preferred (foundation metadata concept)
Ethambutol hydrochloride 275 mg and isoniazid 75 mg and pyrazinamide 400 mg and rifampicin 150 mg oral tablet	Acceptable (foundation metadata concept)
Ethambutol hydrochloride 275 mg and isoniazid 75 mg and pyrazinamide 400 mg and rifampin 150 mg oral tablet	Preferred (foundation metadata concept)
Ethambutol hydrochloride 275 mg and isoniazid 75 mg and rifampicin 150 mg oral tablet	Acceptable (foundation metadata concept)
Ethambutol hydrochloride 275 mg and isoniazid 75 mg and rifampin 150 mg oral tablet	Preferred (foundation metadata concept)
Ethambutol hydrochloride 400 mg oral tablet	Preferred (foundation metadata concept)
Ethambutol only product	Preferred (foundation metadata concept)
Ethanoic acid	Acceptable (foundation metadata concept)
Ethanol	Preferred (foundation metadata concept)
Ethanol (substance)	Preferred (foundation metadata concept)
Ethanol 0.7 mL/mL cutaneous solution	Preferred (foundation metadata concept)
Ethanol abuse	Acceptable (foundation metadata concept)
Ethanol only product	Preferred (foundation metadata concept)
Ethanol-induced mood disorder	Acceptable (foundation metadata concept)
Ethanol-induced organic mental disorder	Acceptable (foundation metadata concept)
Ethanol-induced psychosis	Acceptable (foundation metadata concept)
Ethanolamine	Preferred (foundation metadata concept)
Ethanolamine (substance)	Preferred (foundation metadata concept)
Ethanolamine and/or ethanolamine derivative	Preferred (foundation metadata concept)
Ethanolamine and/or ethanolamine derivative (substance)	Preferred (foundation metadata concept)
Ethene homopolymer	Acceptable (foundation metadata concept)
Ethenol homopolymer	Acceptable (foundation metadata concept)
Ethenylbenzene	Acceptable (foundation metadata concept)
Ethinyl estradiol	Preferred (foundation metadata concept)
Ethinyl estradiol 30 microgram and levonorgestrel 150 microgram oral tablet	Preferred (foundation metadata concept)
Ethinyl estradiol 35 microgram and norethindrone 1 mg oral tablet	Preferred (foundation metadata concept)
Ethinyl estradiol and levonorgestrel only product	Preferred (foundation metadata concept)
Ethinyl estradiol and norethindrone only product	Preferred (foundation metadata concept)
Ethinylestradiol	Acceptable (foundation metadata concept)
Ethinylestradiol (substance)	Preferred (foundation metadata concept)
Ethinylestradiol 30 microgram and levonorgestrel 150 microgram oral tablet	Acceptable (foundation metadata concept)
Ethinylestradiol 35 microgram and norethisterone 1 mg oral tablet	Acceptable (foundation metadata concept)
Ethinylestradiol and levonorgestrel only product	Acceptable (foundation metadata concept)
Ethinylestradiol and norethisterone only product	Acceptable (foundation metadata concept)

Start Previous Page 173 of 579 Next End

Reference Sets

Reference set descriptor

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
900000000001115012	United States of America English language reference set	en	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	IPS terminology module (core metadata concept)
900000000001116013	US English	en	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	IPS terminology module (core metadata concept)
900000000001117016	United States of America English language reference set (foundation metadata concept)	en	Fully specified name	Active	Entire term case sensitive (core metadata concept)	IPS terminology module (core metadata concept)